Target intelligence / Profile preview

Spleen deficiency

Molecular classification
Other
01

Overview

Spleen deficiency is a concept from Traditional Chinese Medicine (TCM) rather than a molecular or pharmacological target. In TCM, the "spleen" refers to an organ system responsible for digestion, energy production ("Qi"), nutrient transformation, blood containment, and fluid metabolism—not the anatomical spleen recognized in Western medicine[1][3][6]. Spleen Qi deficiency describes a pattern of symptoms such as fatigue, poor appetite, bloating after meals, loose stools or diarrhea, easy bruising, muscle weakness/heaviness, brain fog/difficulty concentrating—often attributed to factors like poor diet (especially cold/raw foods), overthinking/stress/mental strain, chronic illness or irregular eating habits[1][3][5][7]. Modern research has attempted to correlate this syndrome with measurable changes at the metabolic level—such as altered levels of certain metabolites and trace elements—and with changes in gut microbiota composition. However, there is no single molecule/receptor/protein that corresponds to "spleen deficiency"; it is not a receptor/enzyme/transporter/other canonical drug target but rather a holistic diagnostic category within TCM theory[2][4][6]. Some herbal formulas traditionally used to treat spleen deficiency have been studied for their effects on gut flora diversity and metabolic markers; these include Si Junzi Tang and others. Experimental biomarkers such as Shannon's index from ERIC-PCR analysis have been proposed for animal models but do not correspond to specific human molecular targets[8]. In summary: "Spleen deficiency" is not a therapeutic target molecule/receptor; it is an imprecise syndrome diagnosis unique to Traditional Chinese Medicine without direct correspondence to any known protein/gene/drug target.

Other names
Spleen Qi deficiencyPi-deficiency (in TCM literature)Spleen deficiency syndromeSpleen Qi Xu
02

Mechanism of action

Modulation of gut microbiota diversity and function[8] Regulation of digestive/metabolic pathways as interpreted in TCM (*Note*: Mechanisms are based on traditional concepts and some modern correlates but not molecular targets.)

03

Biological functions

Other
04

Disease associations

Other
05

Interacting drugs

Si Junzi Tang (herbal formula)

4 more in the full profile.

06

Biomarkers

Shannon’s index (H’) of ERIC-PCR fingerprints for gut microbiota diversity[8]Sorenson’s pairwise similarity coefficient (Cs) for microbial community similarity[8]

Beyond the preview

Go deeper on Spleen deficiency.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spleen deficiency.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call